Abstract Details

Title Prevalence of Anti-JCV Antibodies in MS Patients Receiving or Considering Treatment with Natalizumab: Baseline Results of STRATIFY-1

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 136

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Carmen Bozic, MD (Biogen Idec)	No disclosure on file
Sandra R. Richman, MD	No disclosure on file
	No disclosure on file
	No disclosure on file
Michaela Tyblova (Nurologicka Klinika 1 LF UK)	No disclosure on file
	No disclosure on file
Meena Subramanyam, PhD	No disclosure on file

��ɫ��